Not finding it? Sign in to also search OpenAlex live.
-
Domain Adaptation via Simulation Parameter and Data Perturbation for Predictive Maintenance2024 PHM Society European Conference conference-abstract Engineering Machine Fault Diagnosis Techniques Open access
Kiavash Fathi, Fabio Corradini, Marcin Sadurski, Marco Silvestri, Marko Ristin, Afrooz Laghaei, +3 more
0citations -
P47 Re-treatment with filgotinib in patients with ulcerative colitis following treatment interruption: SELECTION and SELECTIONLTE data2022 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ben Morison, Severine Vermiere, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, +2 more
0citations -
P45 Combining clinical, biological, and health-related quality of life remission with endoscopic improvements: data from SELECTION2022 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ben Morison, Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, +4 more
0citations -
P46 Efficacy and safety of long-term treatment with filgotinib for ulcerative colitis: data from SELECTIONLTE2022 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ben Morison, Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, Margaux Faes, Alessandra Faria Oortwijn, +4 more
1citations -
Characteristics and Outcomes of Newly Diagnosed Multiple Myeloma Patients with and without Extramedullary Disease after Autologous Transplant and Maintenance Therapy: A Study from the Cmwp-EBMT
Nico Gagelmann, Dirk‐Jan Eikema, Linda Köster, Tanja Netelenbos, Andrew Bruce McDonald, Anne‐Marie Stoppa, +19 more
0citations -
Epcoritamab with rituximab + lenalidomide (R2) in previously untreated (1L) follicular lymphoma (FL) and epcoritamab maintenance in FL: EPCORE NHL-2 arms 6 and 7.2024 Journal of Clinical Oncology conference-abstract Medicine Lymphoma Diagnosis and Treatment Open access
Leslie A. Lori, Lorenzo Falchi, Joost S.P. Vermaat, Gerardo Musuraca, David Belada, Marcel Nijland, +8 more
9citations -
Maintenance after Autologous Hematopoietic Cell Transplantation Improves Overall Survival and Progression Free Survival Regardless of Disease Stage at Transplant in Newly Diagnosed Myeloma Patients: A Global, Real-World Analysis from the Worldwide Network for Blood and Marrow Transplantation Global Study
Andrew J. Cowan, Luuk A. Gras, Hiroyuki Takamatsu, Linda Köster, Laurien G.A. Baaij, Nada Hamad, +44 more
0citations -
Epcoritamab with rituximab + lenalidomide (R2) and epcoritamab maintenance deliver deep and durable remissions in previously untreated (1L) follicular lymphoma (FL): 3-year outcomes from epcore NHL-2 arms 6 and 7
Lori Ann Leslie, Gerardo Musuraca, Pau Abrisqueta, Joshua Brody, Jacob Haaber Christensen, Alexander Fosså, +8 more
2citations -
P17.06.A VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)
Marjolein Geurts, Émilie Le Rhun, Johnny Duerinck, Enrico Franceschi, Mehdi Touat, Andrea Pace, +12 more
1citations -
CTNI-09. VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)
Marjolein Geurts, Emilie LeRhun, Giuseppe Minniti, Marta Padovan, Johnny Duerinck, Enrico Franceschi, +13 more
0citations -
A Phase 3 Large International Noninferiority Trial (MPOWERED): Assessing Maintenance of Response to Oral Octreotide Capsules in Comparison to Injectable Somatostatin Receptor Ligands2021 Journal of the Endocrine Society conference-abstract Medicine Pituitary Gland Disorders and Treatments Open access
Maria Fleseriu, Alexander Vasil'evich Dreval', Yulia G. Pokramovich, Irina Arkad'evna Bondar', Elena Isaeva, Mark E. Molitch, +13 more
5citations -
Health-Related Quality of Life in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Data from the Perseus Trial of Subcutaneous Daratumumab Combined with Bortezomib, Lenalidomide, and Dexamethasone (D-VRd)
Pieter Sonneveld, Meletios Athanasios Dimopoulos, Mario Boccadoro, Hang Quach, Phoebe Joy Ho, Meral Beksaç, +38 more
1citations -
Real-Life Data of Cyclosporine (CsA) Tapering in Patients with Very/ Severe Aplastic Anemia (v/sAA) Treated with Horse Anti-Thymocyte Globulin (hATG/CsA) Suggest Higher Risk of AA Relapse at Cyclosporine Plasma Levels below 100 Nanogram per Milliliter2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments
Jeanette Walter, Kim Kricheldorf, Yannic Schumacher, Susanne Isfort, Jörg Chromik, Beatrice Drexler, +4 more
2citations -
POS1123 IMPACT OF THE TIME OF INITIATION AND LINE OF BIOLOGIC THERAPY ON THE RETENTION RATE OF SECUKINUMAB (SECU) IN AXIAL SPONDYLOARTHRITIS (AXSPA). DATA FROM THE FRENCH MULTICENTER RETROSPECTIVE FORSYA STUDY
Maxime Dougados, A. Lardy-Cléaud, E. Desfleurs, Pascal Claudepierre, Philippe Goupille, A. Ruyssen-Witrand, +4 more
1citations -
POS0900 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES OVER 2 YEARS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Florian Proft, Désirée M F M van der Heijde, Sergio Schwartzman, Joerg Ermann, A. Marten, Ute Massow, +6 more
0citations -
Impact of rucaparib on circadian rhythms and adverse events in ovarian cancer: Insights from the MAMOC trial.2025 Journal of Clinical Oncology conference-abstract Medicine PARP inhibition in cancer therapy Open access
Deeksha Malhan, Janina Hesse, Nina Nelson, Jessica Nguyen, Ouda Aboumanify, Josefin Garmshausen, +12 more
0citations -
Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study2020 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +15 more
2citations -
P56 Prolonged benefit of filgotinib in patients with ulcerative colitis in SELECTION2023 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ian Beales, David Laharie, Andreas Sturm, Taku Kobayashi, Takayuki Matsumoto, Alessandra Faria Oortwijn, +4 more
0citations -
Synchronous detection of vegetation structures in semi-terrestrial areas of the Rhine via unmanned surface vehicles and unmanned aerial vehicles and its benefits for river management2023 conference-abstract Environmental Science Hydrology and Sediment Transport Processes Open access
Benjamin Eberhardt, Maike Heuner, Thomas Gattung, Issa Hansen, Beat Lüthi, Julian Teege, +3 more
0citations